Jill M. Moore

622 total citations
8 papers, 503 citations indexed

About

Jill M. Moore is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Jill M. Moore has authored 8 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 3 papers in Molecular Biology and 3 papers in Epidemiology. Recurrent topics in Jill M. Moore's work include Immune Response and Inflammation (4 papers), Immune cells in cancer (2 papers) and Mycobacterium research and diagnosis (2 papers). Jill M. Moore is often cited by papers focused on Immune Response and Inflammation (4 papers), Immune cells in cancer (2 papers) and Mycobacterium research and diagnosis (2 papers). Jill M. Moore collaborates with scholars based in United States, United Kingdom and Australia. Jill M. Moore's co-authors include Thomas S. Griffith, Troy J. Kemp, Aaron T. Ludwig, Rebecca L. VanOosten, Xiaohong Chen, Michael A. O’Donnell, Yi Luo, Kevin G. Leidal, Bahri Karaçay and William M. Nauseef and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer Research.

In The Last Decade

Jill M. Moore

8 papers receiving 497 citations

Peers

Jill M. Moore

IMMUN

MB

SURGE

ONCOL

EPIDE

Alban Giese France

Seth R. Ogden United States

Chupeng Hu China

Zensho Ito Japan

Irena Ruggiero Poland

Isaac Downs United States

Eva Brencicova United Kingdom

Philipp Stüve Germany

Anne Israelsson Sweden

Alban Giese France

Jill M. Moore

157 ×0.6

IMMUN

145 ×0.6

MB

186 ×1.3

SURGE

106 ×0.8

ONCOL

55 ×0.8

EPIDE

Citations per year, relative to Jill M. Moore Jill M. Moore (= 1×) peers Alban Giese

Countries citing papers authored by Jill M. Moore

Since Specialization

Citations

This map shows the geographic impact of Jill M. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill M. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill M. Moore more than expected).

Fields of papers citing papers by Jill M. Moore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jill M. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill M. Moore. The network helps show where Jill M. Moore may publish in the future.

Co-authorship network of co-authors of Jill M. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Jill M. Moore. A scholar is included among the top collaborators of Jill M. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jill M. Moore. Jill M. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Morrison, Lynne, et al.. (2020). 18132 Hydroxychloroquine for refractory oral lichen planus. Journal of the American Academy of Dermatology. 83(6). AB92–AB92. 2 indexed citations

2.

Simons, Mark P., Jill M. Moore, Troy J. Kemp, & Thomas S. Griffith. (2006). Identification of the Mycobacterial Subcomponents Involved in the Release of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand from Human Neutrophils. Infection and Immunity. 75(3). 1265–1271. 37 indexed citations

3.

VanOosten, Rebecca L., Jill M. Moore, Aaron T. Ludwig, & Thomas S. Griffith. (2005). Depsipeptide (FR901228) Enhances the Cytotoxic Activity of TRAIL by Redistributing TRAIL Receptor to Membrane Lipid Rafts. Molecular Therapy. 11(4). 542–552. 62 indexed citations

4.

VanOosten, Rebecca L., Jill M. Moore, Bahri Karaçay, & Thomas S. Griffith. (2005). Histone deacetylase inhibitors modulate renal cell carcinoma sensitivity to TRAIL/Apo-2L-induced apoptosis by enhancing TRAIL-R2 expression. Cancer Biology & Therapy. 4(10). 1104–1112. 45 indexed citations

5.

Moore, Jill M. & Nina R. Salama. (2005). Mutational Analysis of Metronidazole Resistance in Helicobacter pylori. Antimicrobial Agents and Chemotherapy. 49(3). 1236–1237. 20 indexed citations

6.

Kemp, Troy J., Aaron T. Ludwig, Jill M. Moore, et al.. (2005). Neutrophil stimulation with Mycobacterium bovis bacillus Calmette-Guerin (BCG) results in the release of functional soluble TRAIL/Apo-2L. Blood. 106(10). 3474–3482. 102 indexed citations

7.

Kemp, Troy J., Jill M. Moore, & Thomas S. Griffith. (2004). Human B Cells Express Functional TRAIL/Apo-2 Ligand after CpG-Containing Oligodeoxynucleotide Stimulation. The Journal of Immunology. 173(2). 892–899. 88 indexed citations

8.

Ludwig, Aaron T., Jill M. Moore, Yi Luo, et al.. (2004). Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand. Cancer Research. 64(10). 3386–3390. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact